INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 131 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,000 | -86.7% | 994 | -91.1% | 0.00% | – |
| Q3 2017 | $15,000 | -63.4% | 11,161 | -57.7% | 0.00% | – |
| Q2 2017 | $41,000 | -51.8% | 26,396 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $85,000 | +150.0% | 26,396 | +5.9% | 0.00% | – |
| Q4 2016 | $34,000 | +88.9% | 24,920 | +115.0% | 0.00% | – |
| Q3 2016 | $18,000 | -69.5% | 11,591 | +3.5% | 0.00% | -100.0% |
| Q1 2016 | $59,000 | -57.2% | 11,194 | -11.4% | 0.00% | 0.0% |
| Q2 2015 | $138,000 | – | 12,635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
| EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
| Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
| Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
| MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
| Bleichroeder LP | 250,000 | $298,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
| Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |